Patterns and Predictors of Depression Treatment among Stroke Survivors with Depression in Ambulatory Settings in the United States

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Goal: Despite the importance of treating depression, little is known regarding the current practice pattern of depression treatment among older adults with stroke and depression. We used national survey data from ambulatory settings to examine the depression treatment patterns and predictors among stroke survivors in the United States (US). Materials and Methods: We used a cross-sectional study design by pooling multiple-year data (2005-2011) from the National Ambulatory Medical Care Survey and the outpatient department of the National Hospital Ambulatory Medical Care Survey. Older adults (age ≥50 years) with stroke and depression constituted the final study sample. Depression treatment defined as antidepressant use with or without psychotherapy was the dependent variable in this study. All analyses adjusted for the complex survey design of the datasets to obtain nationally representative estimates. Findings: The overall depression treatment was observed in 47.32% of the study sample, mainly driven by antidepressant use alone. An overwhelming majority used selective serotonin reuptake inhibitors (77% of overall antidepressant use), and sertraline was the most prescribed antidepressant (30.5% of overall antidepressant use). Gender, race or ethnicity, region of residence, number of medications recorded at the sampled visit, and number of chronic conditions were significantly associated with depression treatment. Conclusion: According to this nationally representative sample, approximately 1 in 2 stroke survivors with depression received depression treatment in ambulatory care settings in the US. Appropriate interventions should be developed to optimize depression treatment.

Original languageEnglish (US)
JournalJournal of Stroke and Cerebrovascular Diseases
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Survivors
Stroke
Depression
Antidepressive Agents
Therapeutics
Health Care Surveys
Sertraline
Hospital Departments
Serotonin Uptake Inhibitors
Ambulatory Care
Psychotherapy
Outpatients
Cross-Sectional Studies

Keywords

  • Ambulatory care settings
  • Antidepressants
  • Depression
  • Older adults
  • Psychotherapy
  • Stroke

ASJC Scopus subject areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

@article{0a56456673974948a3d126d6e292826e,
title = "Patterns and Predictors of Depression Treatment among Stroke Survivors with Depression in Ambulatory Settings in the United States",
abstract = "Goal: Despite the importance of treating depression, little is known regarding the current practice pattern of depression treatment among older adults with stroke and depression. We used national survey data from ambulatory settings to examine the depression treatment patterns and predictors among stroke survivors in the United States (US). Materials and Methods: We used a cross-sectional study design by pooling multiple-year data (2005-2011) from the National Ambulatory Medical Care Survey and the outpatient department of the National Hospital Ambulatory Medical Care Survey. Older adults (age ≥50 years) with stroke and depression constituted the final study sample. Depression treatment defined as antidepressant use with or without psychotherapy was the dependent variable in this study. All analyses adjusted for the complex survey design of the datasets to obtain nationally representative estimates. Findings: The overall depression treatment was observed in 47.32{\%} of the study sample, mainly driven by antidepressant use alone. An overwhelming majority used selective serotonin reuptake inhibitors (77{\%} of overall antidepressant use), and sertraline was the most prescribed antidepressant (30.5{\%} of overall antidepressant use). Gender, race or ethnicity, region of residence, number of medications recorded at the sampled visit, and number of chronic conditions were significantly associated with depression treatment. Conclusion: According to this nationally representative sample, approximately 1 in 2 stroke survivors with depression received depression treatment in ambulatory care settings in the US. Appropriate interventions should be developed to optimize depression treatment.",
keywords = "Ambulatory care settings, Antidepressants, Depression, Older adults, Psychotherapy, Stroke",
author = "Sandipan Bhattacharjee and Axon, {David Rhys} and Goldstone, {Lisa Whittington} and Lee, {Jeannie K}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2017.09.047",
language = "English (US)",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Patterns and Predictors of Depression Treatment among Stroke Survivors with Depression in Ambulatory Settings in the United States

AU - Bhattacharjee, Sandipan

AU - Axon, David Rhys

AU - Goldstone, Lisa Whittington

AU - Lee, Jeannie K

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Goal: Despite the importance of treating depression, little is known regarding the current practice pattern of depression treatment among older adults with stroke and depression. We used national survey data from ambulatory settings to examine the depression treatment patterns and predictors among stroke survivors in the United States (US). Materials and Methods: We used a cross-sectional study design by pooling multiple-year data (2005-2011) from the National Ambulatory Medical Care Survey and the outpatient department of the National Hospital Ambulatory Medical Care Survey. Older adults (age ≥50 years) with stroke and depression constituted the final study sample. Depression treatment defined as antidepressant use with or without psychotherapy was the dependent variable in this study. All analyses adjusted for the complex survey design of the datasets to obtain nationally representative estimates. Findings: The overall depression treatment was observed in 47.32% of the study sample, mainly driven by antidepressant use alone. An overwhelming majority used selective serotonin reuptake inhibitors (77% of overall antidepressant use), and sertraline was the most prescribed antidepressant (30.5% of overall antidepressant use). Gender, race or ethnicity, region of residence, number of medications recorded at the sampled visit, and number of chronic conditions were significantly associated with depression treatment. Conclusion: According to this nationally representative sample, approximately 1 in 2 stroke survivors with depression received depression treatment in ambulatory care settings in the US. Appropriate interventions should be developed to optimize depression treatment.

AB - Goal: Despite the importance of treating depression, little is known regarding the current practice pattern of depression treatment among older adults with stroke and depression. We used national survey data from ambulatory settings to examine the depression treatment patterns and predictors among stroke survivors in the United States (US). Materials and Methods: We used a cross-sectional study design by pooling multiple-year data (2005-2011) from the National Ambulatory Medical Care Survey and the outpatient department of the National Hospital Ambulatory Medical Care Survey. Older adults (age ≥50 years) with stroke and depression constituted the final study sample. Depression treatment defined as antidepressant use with or without psychotherapy was the dependent variable in this study. All analyses adjusted for the complex survey design of the datasets to obtain nationally representative estimates. Findings: The overall depression treatment was observed in 47.32% of the study sample, mainly driven by antidepressant use alone. An overwhelming majority used selective serotonin reuptake inhibitors (77% of overall antidepressant use), and sertraline was the most prescribed antidepressant (30.5% of overall antidepressant use). Gender, race or ethnicity, region of residence, number of medications recorded at the sampled visit, and number of chronic conditions were significantly associated with depression treatment. Conclusion: According to this nationally representative sample, approximately 1 in 2 stroke survivors with depression received depression treatment in ambulatory care settings in the US. Appropriate interventions should be developed to optimize depression treatment.

KW - Ambulatory care settings

KW - Antidepressants

KW - Depression

KW - Older adults

KW - Psychotherapy

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85032748612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032748612&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2017.09.047

DO - 10.1016/j.jstrokecerebrovasdis.2017.09.047

M3 - Article

C2 - 29097059

AN - SCOPUS:85032748612

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

ER -